| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-5002(01)00225-2 |
| P8608 | Fatcat ID | release_vvqwdd5y5vc2jmcdkz25luwdaq |
| P698 | PubMed publication ID | 11679179 |
| P2093 | author name string | H Kato | |
| K Nagashima | |||
| M Jin | |||
| M Arakawa | |||
| S Inoue | |||
| T Umemura | |||
| J Moriya | |||
| P2860 | cites work | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 |
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| G1 phase progression: cycling on cue | Q29615162 | ||
| Mammalian G1 cyclins | Q29618855 | ||
| Performance and prognosis in patients with lung cancer. The Edinburgh Lung Cancer Group | Q36235429 | ||
| Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study | Q39788280 | ||
| Cyclins and their associated cyclin-dependent kinases in the human cell cycle | Q40727258 | ||
| Prognostic value of the quantified expression of p185 in non-small cell lung cancer. | Q40762548 | ||
| Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma. | Q53332429 | ||
| c-mos immunoreactivity is an indicator of good prognosis in lung cancer | Q58068762 | ||
| RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines | Q72864210 | ||
| Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis | Q73190728 | ||
| Identification of prognostic factors determining risk groups for lung resection | Q73198371 | ||
| The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung | Q73268970 | ||
| In vitro confirmation of newly established lung cancer cell lines using flow cytometry and multicellular tumor spheroids | Q73439097 | ||
| Prognostic implications of a positive bronchial resection margin | Q73801123 | ||
| Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung | Q73821349 | ||
| Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome | Q73955112 | ||
| Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases | Q74060940 | ||
| Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend | Q74108094 | ||
| Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer? | Q74152934 | ||
| Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative | Q74239269 | ||
| Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2 | Q74319403 | ||
| Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer | Q74339046 | ||
| Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer | Q74341438 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| retinoblastoma | Q500695 | ||
| P304 | page(s) | 207-18 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II | |
| P478 | volume | 34 |
| Q28395274 | A review of molecular events of cadmium-induced carcinogenesis |
| Q40197534 | Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. |
| Q47932543 | CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response |
| Q28530421 | CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer |
| Q54673900 | CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer. |
| Q38199197 | Cell cycle inhibitors for the treatment of NSCLC. |
| Q53494880 | Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study. |
| Q37393770 | Chronic cadmium exposure in vitro induces cancer cell characteristics in human lung cells. |
| Q64078589 | Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules |
| Q64066817 | Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer |
| Q34542602 | Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis |
| Q52877460 | Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. |
| Q35179461 | Cyclin D1 as a target for chemoprevention |
| Q41297044 | Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer |
| Q34346323 | Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer |
| Q47906539 | Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer |
| Q54417112 | Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma. |
| Q35532215 | EPMA position paper in cancer: current overview and future perspectives |
| Q38103251 | Flipping the switch from g1 to s phase with e3 ubiquitin ligases |
| Q36994736 | Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability |
| Q34712629 | How bacteria could cause cancer: one step at a time. |
| Q43121444 | Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer. |
| Q35770249 | Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation |
| Q36121407 | Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer. |
| Q39304903 | Investigation of effects and mechanisms of total flavonoids of Astragalus and calycosin on human erythroleukemia cells |
| Q38794988 | Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma |
| Q38663358 | MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2. |
| Q34570975 | MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma |
| Q37913090 | Molecular predictors of prognosis in lung cancer |
| Q38878493 | NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells |
| Q86277819 | No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample |
| Q24303548 | Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase |
| Q39258788 | Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication |
| Q37470373 | Nuclear cyclin D1: an oncogenic driver in human cancer |
| Q37225394 | Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas |
| Q28393146 | Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer |
| Q36329257 | Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report. |
| Q37996270 | Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer |
| Q35200555 | Prognostic markers in lung cancer: is it ready for prime time? |
| Q81612566 | Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC) |
| Q35750000 | RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis |
| Q36448676 | Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer |
| Q64236786 | Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer |
| Q37111920 | Role of DMP1 and its future in lung cancer diagnostics |
| Q28394676 | Role of cell cycle regulators in lung carcinogenesis |
| Q28592198 | The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation |
| Q28067196 | The Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung Cancer |
| Q44763194 | The role of CCND1 alterations during the progression of cutaneous malignant melanoma |
| Q37420066 | Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors |
| Q37010207 | p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis |
Search more.